Cargando…
The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors
The mechanisms of chemotherapy resistance in triple negative breast cancer remain unclear, and so, new molecules which might mediate this resistance could optimize treatment response. Here we analyzed the involvement of the miRNA-449 family in the response to doxorubicin. The cell viability, cell-cy...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441107/ https://www.ncbi.nlm.nih.gov/pubmed/30926829 http://dx.doi.org/10.1038/s41598-019-41472-y |
_version_ | 1783407491759996928 |
---|---|
author | Tormo, Eduardo Ballester, Sandra Adam-Artigues, Anna Burgués, Octavio Alonso, Elisa Bermejo, Begoña Menéndez, Silvia Zazo, Sandra Madoz-Gúrpide, Juan Rovira, Ana Albanell, Joan Rojo, Federico Lluch, Ana Eroles, Pilar |
author_facet | Tormo, Eduardo Ballester, Sandra Adam-Artigues, Anna Burgués, Octavio Alonso, Elisa Bermejo, Begoña Menéndez, Silvia Zazo, Sandra Madoz-Gúrpide, Juan Rovira, Ana Albanell, Joan Rojo, Federico Lluch, Ana Eroles, Pilar |
author_sort | Tormo, Eduardo |
collection | PubMed |
description | The mechanisms of chemotherapy resistance in triple negative breast cancer remain unclear, and so, new molecules which might mediate this resistance could optimize treatment response. Here we analyzed the involvement of the miRNA-449 family in the response to doxorubicin. The cell viability, cell-cycle phases, and the expression of in silico target genes and proteins of sensitive/resistant triple negative breast cancer cell lines were evaluated in response to doxorubicin treatment and after gain/loss of miRNAs-449 function achieved by transient transfection. Triple negative breast cancer patients were selected for ex vivo experiments and to evaluate gene and miRNAs expression changes after treatment, as well as survival analysis by Kaplan-Meier. Doxorubicin treatment upregulated miRNAs-449 and DNA-damage responder factors E2F1 and E2F3 in triple negative breast cancer sensitive breast cancer cells, while expression remained unaltered in resistant ones. In vitro overexpression of miRNAs-449 sensitized cells to the treatment and significantly reduced the resistance to doxorubicin. These changes showed also a strong effect on cell cycle regulation. Finally, elevated levels of miRNA-449a associated significantly with better survival in chemotherapy-treated triple negative breast cancer patients. These results reveal for the first time the involvement of the miRNA-449 family in doxorubicin resistance and their predictive and prognostic value in triple negative breast cancer patients. |
format | Online Article Text |
id | pubmed-6441107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-64411072019-04-04 The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors Tormo, Eduardo Ballester, Sandra Adam-Artigues, Anna Burgués, Octavio Alonso, Elisa Bermejo, Begoña Menéndez, Silvia Zazo, Sandra Madoz-Gúrpide, Juan Rovira, Ana Albanell, Joan Rojo, Federico Lluch, Ana Eroles, Pilar Sci Rep Article The mechanisms of chemotherapy resistance in triple negative breast cancer remain unclear, and so, new molecules which might mediate this resistance could optimize treatment response. Here we analyzed the involvement of the miRNA-449 family in the response to doxorubicin. The cell viability, cell-cycle phases, and the expression of in silico target genes and proteins of sensitive/resistant triple negative breast cancer cell lines were evaluated in response to doxorubicin treatment and after gain/loss of miRNAs-449 function achieved by transient transfection. Triple negative breast cancer patients were selected for ex vivo experiments and to evaluate gene and miRNAs expression changes after treatment, as well as survival analysis by Kaplan-Meier. Doxorubicin treatment upregulated miRNAs-449 and DNA-damage responder factors E2F1 and E2F3 in triple negative breast cancer sensitive breast cancer cells, while expression remained unaltered in resistant ones. In vitro overexpression of miRNAs-449 sensitized cells to the treatment and significantly reduced the resistance to doxorubicin. These changes showed also a strong effect on cell cycle regulation. Finally, elevated levels of miRNA-449a associated significantly with better survival in chemotherapy-treated triple negative breast cancer patients. These results reveal for the first time the involvement of the miRNA-449 family in doxorubicin resistance and their predictive and prognostic value in triple negative breast cancer patients. Nature Publishing Group UK 2019-03-29 /pmc/articles/PMC6441107/ /pubmed/30926829 http://dx.doi.org/10.1038/s41598-019-41472-y Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Tormo, Eduardo Ballester, Sandra Adam-Artigues, Anna Burgués, Octavio Alonso, Elisa Bermejo, Begoña Menéndez, Silvia Zazo, Sandra Madoz-Gúrpide, Juan Rovira, Ana Albanell, Joan Rojo, Federico Lluch, Ana Eroles, Pilar The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors |
title | The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors |
title_full | The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors |
title_fullStr | The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors |
title_full_unstemmed | The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors |
title_short | The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors |
title_sort | mirna-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441107/ https://www.ncbi.nlm.nih.gov/pubmed/30926829 http://dx.doi.org/10.1038/s41598-019-41472-y |
work_keys_str_mv | AT tormoeduardo themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT ballestersandra themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT adamartiguesanna themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT burguesoctavio themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT alonsoelisa themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT bermejobegona themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT menendezsilvia themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT zazosandra themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT madozgurpidejuan themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT roviraana themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT albanelljoan themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT rojofederico themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT lluchana themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT erolespilar themirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT tormoeduardo mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT ballestersandra mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT adamartiguesanna mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT burguesoctavio mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT alonsoelisa mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT bermejobegona mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT menendezsilvia mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT zazosandra mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT madozgurpidejuan mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT roviraana mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT albanelljoan mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT rojofederico mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT lluchana mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors AT erolespilar mirna449familymediatesdoxorubicinresistanceintriplenegativebreastcancerbyregulatingcellcyclefactors |